DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 141 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 11 | -95.3% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 232 | -4.1% | 0.00% | – |
| Q1 2019 | $2,000 | -95.1% | 242 | -94.6% | 0.00% | – |
| Q4 2018 | $41,000 | +355.6% | 4,473 | +515.3% | 0.00% | – |
| Q3 2018 | $9,000 | -18.2% | 727 | -1.0% | 0.00% | – |
| Q2 2018 | $11,000 | -74.4% | 734 | -66.2% | 0.00% | -100.0% |
| Q1 2018 | $43,000 | +7.5% | 2,173 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $40,000 | -13.0% | 2,173 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $46,000 | – | 2,173 | +19654.5% | 0.00% | – |
| Q2 2017 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 11 | -99.8% | 0.00% | -100.0% |
| Q3 2016 | $52,000 | – | 4,958 | +13672.2% | 0.00% | – |
| Q2 2016 | $0 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |